Free, user-friendly 'blood pressure cuff' for dementia is reliable and valid: research
June 14, 2012 in Alzheimer's disease & dementia
A new study shows that a practical clinical tool developed by researchers from the Regenstrief Institute and the Indiana University School of Medicine to measure severity of dementia symptoms is reliable and valid. The Healthy Aging Brain Care Monitor is simple, user-friendly and sensitive to change in symptoms.
"The HABC Monitor is a 'blood pressure cuff' for dementia," said Regenstrief Institute investigator Malaz Boustani, M.D., MPH, associate professor of medicine and associate director of the IU Center for Aging Research. A geriatrician, Dr. Boustani is the study's corresponding author and principal investigator. He is also medical director of the Healthy Aging Brain Center at Wishard Health Services, the public hospital where the study was conducted. "Much as doctors and nurses use a sphygmomanometer -- a blood pressure cuff -- to quickly and repeatedly determine changes in blood pressure, we have developed a 31-item questionnaire to easily measure and track dementia symptoms. The results provide information critical to the clinician's care of older adults as well as to caregiver's well-being."
Divided into clinically relevant domains -- cognitive, functional, and behavioral and psychological symptoms of the patient; and caregiver quality of life -- all questions on the HABC Monitor have the same response options, ranging from never to almost all days. It takes about six minutes for caregiver response.
In the study, 171 caregivers -- three-quarters of whom were female -- completed the HABC Monitor. Fifty-two percent of the caregivers were the children of the patients, 34 percent were spouses, 6 percent were siblings, and 4 percent were grandchildren. Caregivers had a mean age of 58 years. Ninety percent indicated that they knew the patient very well, while 10 percent indicated they knew the patient well.
"We found the HABC Monitor to be highly sensitive to changes in the patient, both declines and improvement," said Patrick Monahan, Ph.D., associate professor of biostatistics at the IU School of Medicine. He is a psychometrician and first author of the new study. "The HABC Monitor is also able to distinguish between groups of patients who differ in severity of impairment based on physician diagnoses and based on other questionnaires that have been validated for research but are too long and time-consuming for clinical practice.
"Depression and anxiety, both very common in older adults with dementia, but often missed during a busy office visit, are highlighted for the clinician. This study confirmed that the HABC Monitor is an accurate measure of dementia symptoms. We are seeking funding to study the impact of this new 'blood pressure cuff' on primary care, where most older adults receive their care."
"A Practical Clinical Tool to Monitor Dementia Symptoms: The HABC-Monitor" was published June 14 in Clinical Interventions in Aging, an international peer-reviewed open-access publication.
Provided by
Indiana University School of Medicine
-
New mode of dementia care improves health, lowers hospitalization rates
Feb 10, 2011 |
not rated yet |
0
-
Dementia care model that reduces hospitalizations successfully translated into practice
May 31, 2012 |
not rated yet |
0
-
Regenstrief extending successful aging brain care model globally
May 02, 2012 |
not rated yet |
0
-
Caring for the caregiver: Redefining the definition of patient
Nov 10, 2008 |
not rated yet |
0
-
Cholinesterase inhibitors reduce aggression, wandering and paranoia in Alzheimer's disease
Dec 09, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Question in reflection and transmission at oblique incidence.
3 hours ago
-
Is this plasma (picture in thread)
4 hours ago
-
Basic physics understanding. Could someone explain?
6 hours ago
-
Change in flux of a transformer
6 hours ago
-
Electric field between parallel plate capacitor
7 hours ago
-
Why angle of projectile has 2 solutions?
8 hours ago
- More from Physics Forums - Classical Physics
More news stories
A new strategy required in the search for Alzheimer's drugs?
In the search for medication against Alzheimer's disease, scientists have focused – among other factors – on drugs that can break down Amyloid beta (A-beta). After all, it is the accumulation of A-beta that causes the ...
Alzheimer's disease & dementia
13 hours ago |
not rated yet |
0
Alzheimer's disease, the soft target of the euthanasia debate
(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.
Alzheimer's disease & dementia
14 hours ago |
not rated yet |
2
Scientists discover cinnamon compounds' potential ability to prevent Alzheimer's
Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of –– or warding off ...
Alzheimer's disease & dementia
May 23, 2013 |
5 / 5 (5) |
0
|
Drug reverses Alzheimer's disease deficits in mice, research confirms
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.
Alzheimer's disease & dementia
May 23, 2013 |
not rated yet |
0
|
Multiple research teams unable to confirm high-profile Alzheimer's study
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
Alzheimer's disease & dementia
May 23, 2013 |
3 / 5 (2) |
3
|
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
Comorbidities common with alopecia areata
(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.